{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:53:05Z","timestamp":1788871985938,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.ejphar.2009.04.006","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T04:15:18Z","timestamp":1239768918000},"page":"87-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Fluvastatin accelerates re-endothelialization impaired by local sirolimus treatment"],"prefix":"10.1016","volume":"612","author":[{"given":"Daiju","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibuki","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryozo","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Sata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2009.04.006_bib1","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2009.04.006_bib2","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1161\/CIRCULATIONAHA.105.609057","article-title":"Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents","volume":"116","author":"Awata","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2009.04.006_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1172\/JCI200113152","article-title":"HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase\/Akt pathway","volume":"108","author":"Dimmeler","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2009.04.006_bib4","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/01.CIR.0000156334.24955.B2","article-title":"Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial","volume":"111","author":"Fajadet","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2009.04.006_bib5","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/ATVBAHA.107.144220","article-title":"Vascular responses to drug eluting stents: importance of delayed healing","volume":"27","author":"Finn","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2009.04.006_bib6","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1161\/01.RES.0000205765.28940.93","article-title":"CD34-\/CD133+\/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities","volume":"98","author":"Friedrich","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2009.04.006_bib7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.CIR.0000155612.47040.17","article-title":"Potent inhibitory effect of sirolimus on circulating vascular progenitor cells","volume":"111","author":"Fukuda","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2009.04.006_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurheartj\/ehi571","article-title":"Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation","volume":"27","author":"Hofma","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2009.04.006_bib9","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"J.A.M.A."},{"key":"10.1016\/j.ejphar.2009.04.006_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2006.06.012","article-title":"Statins and the endothelium","volume":"46","author":"Ii","year":"2007","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.04.006_bib11","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.jacc.2008.01.058","article-title":"Sirolimus-induced vascular dysfunction. Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation","volume":"51","author":"Jabs","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2009.04.006_bib12","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.0000127105.99982.21","article-title":"Stent thrombosis after successful sirolimus-eluting stent implantation","volume":"109","author":"Jeremias","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2009.04.006_bib13","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1161\/01.CIR.0000121732.85572.6F","article-title":"Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells","volume":"109","author":"Kong","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2009.04.006_bib14","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.jacc.2005.11.092","article-title":"Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings","volume":"47","author":"Kotani","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2009.04.006_bib15","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa067722","article-title":"Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden","volume":"356","author":"Lagerqvist","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2009.04.006_bib16","first-page":"H161","article-title":"The endothelium modulates the contribution of chloride currents to norepinephrine-induced vascular contraction","volume":"275","author":"Lamb","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2009.04.006_bib17","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/0021-9150(95)90076-4","article-title":"The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator","volume":"118 Suppl","author":"Luscher","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2009.04.006_bib18","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMp038141","article-title":"Sirolimus for the prevention of in-stent restenosis in a coronary artery","volume":"349","author":"Marks","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2009.04.006_bib19","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(04)17275-9","article-title":"Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy","volume":"364","author":"McFadden","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2009.04.006_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacc.2006.08.043","article-title":"Coronary collateral function long after drug-eluting stent implantation","volume":"49","author":"Meier","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2009.04.006_bib21","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2009.04.006_bib22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/01.ATV.0000254677.12861.b8","article-title":"Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents","volume":"27","author":"Muldowney","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2009.04.006_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0014-5793(97)00313-X","article-title":"\u2018Green mice\u2019 as a source of ubiquitous green cells","volume":"407","author":"Okabe","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2009.04.006_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.ejphar.2009.04.006_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/01.HYP.36.1.83","article-title":"Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via a cyclic GMP-independent mechanism","volume":"36","author":"Sata","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2009.04.006_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nm0402-403","article-title":"Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis","volume":"8","author":"Sata","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2009.04.006_bib27","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/01.CIR.0000025585.63486.59","article-title":"Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial","volume":"106","author":"Serruys","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2009.04.006_bib28","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2009.04.006_bib29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jacc.2005.01.062","article-title":"Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction","volume":"46","author":"Togni","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2009.04.006_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.mca.0000131572.14521.8a","article-title":"Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells","volume":"15","author":"Walter","year":"2004","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.ejphar.2009.04.006_bib31","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/hc0602.103393","article-title":"Statins have biphasic effects on angiogenesis","volume":"105","author":"Weis","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2009.04.006_bib32","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1161\/01.ATV.0000036417.43987.D8","article-title":"Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition","volume":"22","author":"Werner","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2009.04.006_bib33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/01.ATV.0000063385.12476.A7","article-title":"Endothelium-dependent effects of statins","volume":"23","author":"Wolfrum","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990900332X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990900332X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:09:54Z","timestamp":1757974194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429990900332X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":33,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S001429990900332X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.04.006","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluvastatin accelerates re-endothelialization impaired by local sirolimus treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}